For employers operating on tight benefit budgets, thats an untenable increase to absorb especially when utilization consistently came in higher than projected. In conversations documented by the Kaiser Family Foundation and Peterson Center on Healthcare, employers described trying multiple cost-management strategies step therapy requirements, prior authorization, weight-loss program prerequisites before ultimately concluding that no guardrail was controlling the spend fast enough. Importantly, the law doesnt require employers to offer GLP-1 coverage
Neuropharmacology 86, 2230
The manufacturer, Novo Nordisk, offers a savings card program that lets you get Wegovy for free, or at least at a discount, if youre eligible
117 ReinerJBerlinPHeldJThieryJSkarbalieneJGriffinJet al
2 Dinesh Mani Tripathi 2 GURESH KUMAR 2 Saggere Muralikrishna Shasthry 2 Shiv Kumar Sarin 2 Savneet kaur 2 , 1 institute of liver and biliary sciences, new delhi, 2 institute of liver and biliary sciences Background: Hyperammonemia is associated with the development of hepatic encephalopathy (HE)
